The ribonucleotide reductase activities in vitamin B 2-sufficient and -deficient cells of Euglena gracilis were measured. We found that as the cells progress into vitamin B12 deficiency the enzyme activity increases, reaching a maximum value of 20-fold in advanced deficiency. No significant differences in the activities were found to result as a consequence of different growth conditions. We propose that the increased activity in vitamin B 2-deficient cells is due to an increase in enzyme protein.
Ribonucleotide reductase catalyses the conversion of the ribonucleotides into the corresponding deoxyribonucleotides. This enzyme system is considered to play a key role in regulating DNA synthesis and subsequent cell division (Elford et al., 1970; Cory & Whitford, 1972; Gleason & Wood, 1976; Lewis et al., 1977) .
With regard to substrate requirement, there are two known types of ribonucleotide reductase. Ribonucleoside diphosphate reductase (EC 1.17.4 .1) catalyses the conversion of ribonucleoside diphosphates and ribonucleoside triphosphate reductase (EC 1.17.4 .2) reduces ribonucleoside triphosphates. These enzymes may be further classified on the basis of their cofactor requirements. Under this scheme, three types of ribonucleotide reductase have been identified. The most extensively studied type reduces the ribonucleoside diphosphates, is inhibited by hydroxyurea, is a non-haem-iron-containing protein, is found in Escherichia coli and appears to be characteristic of mammals and some higher plants (cf. Follman, 1974; Reichard, 1978) . The enzyme found in Lactobacillus leichmannii (Abrams, 1965; Blakley et al., 1965; and Pithomyces chartarum (Stutzenberger, 1974) requires 5'-deoxyadenosylcobalamin as a cofactor and reduces the ribonucleoside triphosphates. The third type is characteristic of Bacillus megaterium (Yau & Wachsman, 1973) and Rhizobium melilote (Cowles & Evans, 1968 (Gleason & Hogenkamp, 1970 Hamilton, 1974 (Carell & Goetz, 1976; Goetz & Carell, 1978) .
A number of studies utilizing inhibitors of DNA synthesis such as hydroxyurea (Murphree et al., 1969) , fluorouracil (Lowdon & Vitols, 1973) and fluorodeoxyuridine and methotrexate (Elford et al., 1977) have resulted in elevated ribonucleotide reductase activities.
In the present paper we show that vitamin B12-deficient Euglena gracilis displays manyfold increases in the activity of this enzyme. Our findings suggest that the increase is due to an increase in enzyme protein rather than to enzyme activation. Experimental Growth conditions Euglena gracilis Klebs strain Z (Pringsheim) and the aplastidic mutant Y7ZHL (Egan & Carell, 1972) were grown in a pH 3.6 medium as previously described (Carell, 1969) . These cells were also grown in a newly developed medium, similar to Hutner's modified medium (Price & Vallee, 1962) , but with K2HPO4 as buffer and titrated to pH6.8 with aq. NH3. Growth measurements in terms of cell number, production of vitamin B12 deficiency and criteria of the deficiency condition have been described (Carell, 1969 Partially purified extracts were prepared by the method of Gleason & Hogenkamp (1970) , modified as follows. Harvested and washed cells were resuspended at 1 x 108/ml for vitamin B12-sufficient and 5 x 107 cells/ml for vitamin B12-deficient cultures. After the addition of neutral Norit-A charcoal, the resulting cell slurries were stored at -800C before sonication. The cells were disrupted by sonic oscillation for 10min at 1 min intervals with a Bronwell-Blackstone 20 KC Biosonik ultrasonic probe. The lysate was then centrifuged twice, the supernatant was dialysed, the nucleic acids were precipitated and centrifuged off, and the supernatant was dialysed as described by Gleason & Hogenkamp (1970) . In our preliminary studies we were unable to detect significant and consistent values for the activity in the partially purified extracts prepared from vitamin BU2-sufficient cells. However, no activity was found in the sediments produced after centrifugation of lysates of either the vitamin BU2-sufficient or the vitamin B12-deficient cells. Also, mixing experiments involving the use of the above precipitates with the partially purified enzyme preparation, in all cases, did not inhibit or add to the activity of these preparations in terms of the amount of product formed per sample. To overcome these difficulties, we freeze-dried the extracts to prepare more highly concentrated preparations of enzyme extract, and this process was adopted as a standard procedure in the preparation of all extracts. The freeze-dried extracts were stored at -200C until assayed. No loss of activity was found with this stored material.
Enzyme assay procedure Ribonucleotide reductase activity was measured as the reduction of ATP to dATP. All other requirements for the assay were as described by Gleason & Hogenkamp (1970) . The amount of dATP formed was determined by the diphenylamine procedure as described by Blakley (1966) . On the basis of the protein content of the freeze-dried extracts, sufficient freeze-dried material was dissolved in 5 mM-dithiothreitol to give the approximate desired protein concentration, centrifuged at 39000g for 45min at 40C, and the supernatant was used for the enzyme assay. Our preliminary studies with extracts prepared in this manner demonstrated that the production of dATP proceeded linearly with time up to about 20min and with initial enzyme concentrations in the ranges 0.25-6.Omg/ml for extracts of vitamin B12-deficient cells, 1.0-8.0mg/ ml for those of exponential-stage cells and 4.0-16.0mg/ml for those of plateau-stage vitamin B12-sufficient cells.
Our standard assay procedure consisted of incubating the reaction mixture at 370C with mixing, with samples taken at 0 and 10min of incubation and treated as described by Gleason & Hogenkamp (1970) , for the determination of dATP production. Samples were also taken for the determination of protein at the end of the assay period. Results are expressed in terms of specific activity, defined as units (nmol of dATP formed/h) per mg of protein.
Protein determinations
Protein concentrations were determined by the method of Lowry et al. (1951) , with purified bovine serum albumin as a standard.
All results are the average of three determinations with triplicate samples taken for each determination.
Results and Discussion
Ribonucleotide reductase activity in vitamin B12-sufficient Euglena
We measured the ribonucleotide reductase activity in both the wild-type Euglena gracilis Z strain and the aplastidic mutant Y7ZHL under different growth conditions. The results (Table 1) show that both cell types harvested in the exponential stage of growth demonstrate the same specific activity, of about 20units/mg, whether grown in the light or in the dark and at either pH 3.6 or 6.8. Both types of cells at the plateau stage of growth show very low or no detectable activity under the different growth conditions, even though we used very highly concentrated extracts.
Our results are comparable with the findings obtained by Gleason & Hogenkamp (1970) Table 2 shows the ribonucleotide reductase Manyfold increases in ribonucleotide reductase activity, as a result of vitamin B12 deficiency, have also been described in other systems. For example, L. leichmannii grown over a nearly 1000-fold range of vitamin B12 concentrations showed about 4-fold increase in the ribonucleotide reductase specific activity with the minimum vitamin B12 concentration . However, our results compare more favourably with those of Fujioka & Silber (1971) , who found a 20-fold increase in the specific activity of the enzyme in megaloblastic bone marrow from patients with vitamin B12 deficiency as compared with normal bone marrow. Previous studies of the human bone-marrow enzyme from patients with pernicious anaemia revealed that the reduction of ribonucleotides occurred at the level of ribonucleoside diphosphates, did not require coenzyme B12 for activity and was inhibited by hydroxyurea (Fujioka & Silber, 1969) . The similarities between vitamin B12-deficiency megaloblastosis in human (cf. Beck, 1975) and vitamin B12 deficiency in Euglena (Carell, 1969; Carell et al., 1970; Christopher et al., 1974) in terms of cell size, RNA, protein and DNA content per cell, extension of the S-phase and the ribonucleotide reductase activity are noteworthy, although the coenzyme does not play the same role in both cases. Much evidence now exists that implicates vitamin B12 deficiency in altered folate metabolism in man (Das & Herbert, 1976) , resulting in megaloblastic maturation as a consequence of impaired methylation of deoxyuridylate to thymidylate (Hoffbrand et al., 1976) .
A number of studies (Murphree et al., 1969; Lowdon & Vitols, 1973; Elford et al., 1977) with inhibitors of DNA synthesis have shown that a decreased ability to synthesize DNA results in elevated ribonucleotide reductase activity. In addition, a number of studies with E. coli (Biswas et al., 1965; Neuhard & Munch-Petersen, 1966) , L. leichmannii and yeast (Lowdon & Vitols, 1973) , as well as a study with mammalian cells (Elford et al., 1977) Follmann, 1974) . Therefore, since it has been shown that the S-phase in vitamin B 12-deficient Euglena is differentially extended (Carell et al., 1970; Christopher et al., 1974) , the synthesis of this enzyme is considered to continue. In addition, Carell & Goetz (1976) and Goetz & Carell (1978) Furthermore, as indicated in Table 2 , whether vitamin B12-deficient Euglena cells are grown in the light or in the dark has no significant effect on the activity. However, the activity in the mutant cells is apparently lower than that found for wild-type cells. We have no explanation to account for this difference other than the possibility involving a chloroplastic ribonucleotide reductase. To our knowledge, no such enzyme has been identified. Although this difference may not be significant, it is tempting to speculate on the existence of a chloroplast-specific ribonucleotide reductase. To test this possibility will require a more sensitive method than used here.
It is noteworthy that a mitochondrial ribonucleotide reductase, from regenerating rat liver cells, has already been identified and had its requirements characterized (Larsson, 1969; Danilova et al., 1977) , and has been found to resemble the type of enzyme found in E. coli.
